{
  "id" : "ss2018_lymphoma_ocular_adnexa_3583",
  "algorithm" : "eod_public",
  "version" : "3.3",
  "name" : "SS2018: Lymphoma Ocular Adnexa",
  "title" : "Summary Stage 2018: Lymphoma Ocular Adnexa",
  "subtitle" : "Summary Stage 2018",
  "notes" : "**Lymphoma Ocular Adnexa**\n\n9590-9699, 9702-9719, 9725-9726, 9734-9738, 9823, 9826-9827, 9930 (C441, C690, C695-C696)\n\n**Note 1:** **Sources used in the development of this chapter**\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)\n* Collaborative Stage Data Collection System, version 02.05:  https://cancerstaging.org/cstage/Pages/default.aspx \n* Chapter 71 *Ocular Adnexal Lymphoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.\n\n**Note 2:** **Not applicable codes** \n* Code 0 is not applicable for this chapter.\n\n**Note 3:** **Ocular adnexal lymphomas** \n* Ocular adnexal lymphomas (OAL) originate in conjunctiva, eyelids, lacrimal gland, lacrimal drainage apparatus, and other orbital tissues surrounding the eye. \n* This chapter should not be used for secondary lymphomatous involvement of ocular adnexa or for intraocular lymphomas.\n\n**Note 4:** **Peripheral blood or bone marrow involvement** \n* If there is peripheral blood or bone marrow involvement, code 7.\n\n**Note 5:** **The preferred histology terms in this schema are based on the 2024 WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition.**\n\n* 9590: Malignant lymphoma, NOS\n* 9591: Malignant lymphoma, non-Hodgkin, NOS\n* 9596: Mediastinal grey zone lymphoma (MGZL)\n* 9597: Primary cutaneous follicle centre lymphoma (PCFCL)\n* 9650: Classic Hodgkin lymphoma (CHL), NOS\n* 9651: Classic Hodgkin lymphoma, lymphocyte-rich (LR-cHL)\n* 9652: Classic Hodgkin lymphoma, mixed cellularity (MC-cHL)\n* 9653: Classic Hodgkin lymphoma, lymphocyte-depleted, NOS (LD-cHL)\n* 9659: Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL)\n* 9663: Classic Hodgkin lymphoma, nodular sclerosis, NOS (NSCHL) \n* 9673: Mantle cell lymphoma (MCL)\n* 9678: Primary effusion lymphoma (PEL)\n* 9679: Primary mediastinal large B-cell lymphoma (PBML/PMBCL)\n* 9680: Diffuse large B-cell lymphoma (DLBCL)\n* 9687: Burkitt lymphoma (BL), NOS\n* 9688: T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL)\n* 9689: Splenic marginal zone lymphoma (SMZL)\n* 9690 Follicular lymphoma (FL), NOS (except C700-C729, C751-C753 for 1/1/2023+)\n* 9691: Follicular lymphoma, grade 2\n* 9695: Follicular lymphoma, grade 1\n* 9698: Follicular lymphoma, grade 3\n* 9699: Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)\n* 9702: Peripheral T-cell lymphoma, NOS\n* 9705: Nodal T follicular helper cell lymphoma, angioimmunoblastic type\n* 9708: Subcutaneous panniculitis-like T-cell lymphoma (SPTCL)\n* 9709: Primary cutaneous peripheral T-cell lymphomas (pcCTCL)\n* 9712: Intravascular large B-cell lymphoma (IVLBCL)\n* 9714: Anaplastic large cell lymphoma, ALK-positive (ALCL)\n* 9715: Anaplastic large cell lymphoma, ALK-negative (ALK-ALCL) (2021+ only)\n* 9716: Hepatosplenic T-cell lymphoma (HSTCL)\n* 9717: Intestinal T-cell lymphoma, NOS (ITCL-NOS)\n* 9718: Primary cutaneous anaplastic large cell lymphoma (C-ALCL)\n* 9719: Extranodal NK/T-cell lymphoma (ENKTL) (except C700-C729, C751-C753 for 1/1/2023+)\n* 9725: Hydroa vacciniforme-like lymphoma (2018-2020 only, nonreportable as of 2021)\n* 9726 Primary cutaneous gamma-delta T-cell lymphoma (PCGD-TCL) (2018-2020 only, see code 9687/3 for 2021+)\n* 9734: Extramedullary plasmacytoma (EMP)\n* 9735: Plasmablastic lymphoma (PBL)\n* 9737: ALK-positive large B-cell lymphoma (ALK+LBCL)\n* 9738: KSHV/HHV8-positive diffuse large B-cell lymphoma \n* 9823: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)\n* 9826: Burkitt cell leukemia (2018-2020 only, see code 9687/3 for 2021+)\n* 9827: Adult T-cell leukemia/lymphoma (ATLL)\n* 9930: Myeloid Sarcoma",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017\n\n(5) Heegaard, S., Finger, P.T., et al. **Ocular Adnexal Lymphoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017",
  "last_modified" : "2025-09-26T14:42:47.444Z",
  "definition" : [ {
    "key" : "ss2018",
    "name" : "SS2018",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  } ],
  "rows" : [ [ "1", "**Localized only (localized, NOS)**\n- Lymphoma involving the conjunctiva alone WITHOUT or UNKNOWN eyelid or orbital involvement\n- Lymphoma with orbital involvement WITH or WITHOUT conjunctival involvement\n- Lymphoma with preseptal eyelid involvement WITH or WITHOUT orbital or conjunctival involvement" ], [ "2", "**Regional by direct extension only**\n- Orbital adnexal lymphoma AND extraorbital lymphoma extending beyond the orbit to adjacent structures\n   + Bone \n   + Brain\n   + Maxillofacial sinuses" ], [ "3", "**Regional lymph node(s) involved only** \n- Cervical\n- Parotid\n- Preauricular\n- Regions draining the ocular adnexal structures\n- Submandibular\n- Regional lymph node(s), NOS\n  + Lymph node(s), NOS" ], [ "4", "**Regional by BOTH direct extension AND regional lymph node(s) involved**\n\nCodes (2) + (3)" ], [ "7", "**Distant site(s)/lymph node(s) involved**\n- Distant sites\n  + Non-contiguous involvement of other extranodal sites including, but not limited to\n     * Breast\n     * Gastrointestinal tract\n     * Kidney\n     * Liver\n     * Lung\n     * Parotid gland\n     * Salivary gland\n     * Spleen\n     * Submandibular gland\n- Distant lymph node(s), NOS\n  + Diffuse OR disseminated involvement of peripheral and central lymph node regions\n  + Mediastinum\n- Distant metastasis, NOS\n  + Blood/peripheral blood\n  + Bone marrow\n  + Distant metastasis WITH or WITHOUT distant lymph node(s)" ], [ "9", "Unknown if extension or metastasis" ] ]
}